These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9773267

  • 1. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
    Lohiya NK, Manivannan B, Mishra PK, Pathak N, Balasubramanian SP.
    Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
    [Abstract] [Full Text] [Related]

  • 2. Preclinical evaluation for noninvasive reversal following long-term vas occlusion with styrene maleic anhydride in langur monkeys.
    Lohiya NK, Manivannan B, Mishra PK, Sriram S, Bhande SS, Panneerdoss S.
    Contraception; 2005 Mar; 71(3):214-26. PubMed ID: 15722073
    [Abstract] [Full Text] [Related]

  • 3. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys.
    Lohiya NK, Manivannan B, Mishra PK.
    Int J Androl; 2000 Feb; 23(1):36-42. PubMed ID: 10632760
    [Abstract] [Full Text] [Related]

  • 4. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal.
    Manivannan B, Mishra PK, Lohiya NK.
    Contraception; 1999 Feb; 59(2):137-44. PubMed ID: 10361629
    [Abstract] [Full Text] [Related]

  • 5. Ultrastructural changes in the spermatozoa of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride.
    Lohiya NK, Manivannan B, Mishra PK.
    Contraception; 1998 Feb; 57(2):125-32. PubMed ID: 9589840
    [Abstract] [Full Text] [Related]

  • 6. Non-invasive reversal of intraluminal vas deferens polymer injection-induced azoospermia--technology.
    Guha SK.
    Asian J Androl; 1999 Sep; 1(3):131-4. PubMed ID: 11250780
    [Abstract] [Full Text] [Related]

  • 7. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
    Guha SK, Ansari S, Anand S, Farooq A, Misro MM, Sharma DN.
    Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
    [Abstract] [Full Text] [Related]

  • 8. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK, Singh G, Ansari S, Kumar S, Srivastava A, Koul V, Das HC, Malhotra RL, Das SK.
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chloroform extract of Carica papaya seeds induces long-term reversible azoospermia in langur monkey.
    Lohiya NK, Manivannan B, Mishra PK, Pathak N, Sriram S, Bhande SS, Panneerdoss S.
    Asian J Androl; 2002 Mar; 4(1):17-26. PubMed ID: 11907624
    [Abstract] [Full Text] [Related]

  • 11. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
    Singh AK.
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
    [No Abstract] [Full Text] [Related]

  • 12. Status of spermatogenesis and sperm parameters in langur monkeys following long-term vas occlusion with styrene maleic anhydride.
    Mishra PK, Manivannan B, Pathak N, Sriram S, Bhande SS, Panneerdoss S, Lohiya NK.
    J Androl; 2003 Oct; 24(4):501-9. PubMed ID: 12826690
    [Abstract] [Full Text] [Related]

  • 13. Contraception with RISUG® and functional reversal through DMSO and NaHCO3 in male rabbits.
    Ansari AS, Badar A, Balasubramanian K, Lohiya NK.
    Asian J Androl; 2017 Oct; 19(4):389-395. PubMed ID: 27586026
    [Abstract] [Full Text] [Related]

  • 14. Safety evaluation of long-term vas occlusion with styrene maleic anhydride and its non-invasive reversal on accessory reproductive organs in langurs.
    Manivannan B, Bhande SS, Panneerdoss S, Sriram S, Lohiya NK.
    Asian J Androl; 2005 Jun; 7(2):195-204. PubMed ID: 15897977
    [Abstract] [Full Text] [Related]

  • 15. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
    Guha SK.
    Med Hypotheses; 2005 Jun; 65(1):61-4. PubMed ID: 15893119
    [Abstract] [Full Text] [Related]

  • 16. Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta.
    Sethi N, Srivastava RK, Nath D, Singh RK.
    J Med Primatol; 1991 Jun; 20(2):89-93. PubMed ID: 1865485
    [Abstract] [Full Text] [Related]

  • 17. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.
    Sharma RS, Mathur AK, Singh R, Das HC, Singh GJ, Toor DPS, Guha SK.
    Indian J Med Res; 2019 Jul; 150(1):81-86. PubMed ID: 31571633
    [Abstract] [Full Text] [Related]

  • 18. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.
    Lohiya NK, Suthar R, Khandelwal A, Goyal S, Ansari AS, Manivannan B.
    Int J Androl; 2010 Feb; 33(1):e198-206. PubMed ID: 19811546
    [Abstract] [Full Text] [Related]

  • 19. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
    Ansari AS, Hussain M, Khan SR, Lohiya NK.
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [Abstract] [Full Text] [Related]

  • 20. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK, Singh G, Anand S, Ansari S, Kumar S, Koul V.
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.